Considering that tumor acidosis is known to be a significant burden for immune functions, Chafe and coworkers reported an expanded study on the potential of CA IX inhibition to enhance the immune checkpoint blockade effect in cancer (Figure 17) [88]. This evidence concerns the gene CA9 and cancer.